Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 11/2013

01.11.2013 | Original Paper

Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility

verfasst von: Ángela Gutiérrez-Camino, Elixabet López-López, Idoia Martín-Guerrero, José Sánchez-Toledo, Nagore García de Andoin, Ana Carboné Bañeres, Purificación García-Miguel, Aurora Navajas, África García-Orad

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Single-nucleotide polymorphisms (SNPs) in AT-rich interactive domain 5B (ARID5B) have been associated with risk for pediatric acute lymphoblastic leukemia (ALL). After reviewing previous studies, we realized that the most significant associations were restricted to intron 3, but the mechanism(s) by which those SNPs affect ALL risk remain to be elucidated. Therefore, the aim of this study was to analyze the association between genetic variants of the intron 3 region of ARID5B and the incidence of B-ALL in a Spanish population. We also aimed to find a functional explanation for the association, searching for copy number variations (CNVs), and changes in ARID5B expression associated with the genotypes of the SNPs.

Methods

We analyzed 10 SNPs in intron 3 of ARID5B in a Spanish population of 219 B-ALL patients and 397 unrelated controls with the Taqman Open Array platform. CNVs were analyzed in 23 patients and 17 controls using the Cytogenetics Whole-genome 2.7 M platform. Expression of ARID5B transcript 1 was quantified by qPCR and related to SNPs genotype in seven ALL cell lines.

Results

Association between intron 3 and B-ALL risk was confirmed for all of the SNPs evaluated in our Spanish population. We could not explain this association by the presence of CNVs. We neither detected changes in the expression of ARID5B isoform associated with the genotype of the SNPs.

Conclusions

The intron 3 of ARID5B gene was found to be strongly associated with B-ALL risk in the Spanish population examined. However, neither CNVs nor changes in mRNA expression were found to be responsible for this association.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Bourquin JP, Subramanian A et al (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 103(9):3339–3344PubMedCrossRef Bourquin JP, Subramanian A et al (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 103(9):3339–3344PubMedCrossRef
Zurück zum Zitat Chang LW, Payton JE et al (2008) Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol 9(2):R38PubMedCrossRef Chang LW, Payton JE et al (2008) Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol 9(2):R38PubMedCrossRef
Zurück zum Zitat Ellinghaus E, Stanulla M et al (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26(5):902–909PubMedCrossRef Ellinghaus E, Stanulla M et al (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26(5):902–909PubMedCrossRef
Zurück zum Zitat Gusev A, Lowe JK et al (2009) Whole population, genome-wide mapping of hidden relatedness. Genome Res 19(2):318–326PubMedCrossRef Gusev A, Lowe JK et al (2009) Whole population, genome-wide mapping of hidden relatedness. Genome Res 19(2):318–326PubMedCrossRef
Zurück zum Zitat Han S, Lee KM et al (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 34(10):1271–1274PubMedCrossRef Han S, Lee KM et al (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 34(10):1271–1274PubMedCrossRef
Zurück zum Zitat Healy J, Richer C et al (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95(9):1608–1611PubMedCrossRef Healy J, Richer C et al (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95(9):1608–1611PubMedCrossRef
Zurück zum Zitat Huang L, Yu D et al (2012) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 33(1):94–100PubMedCrossRef Huang L, Yu D et al (2012) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 33(1):94–100PubMedCrossRef
Zurück zum Zitat Johnston WT, Lightfoot TJ et al (2010) Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 34(6):659–666PubMedCrossRef Johnston WT, Lightfoot TJ et al (2010) Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 34(6):659–666PubMedCrossRef
Zurück zum Zitat Klipper-Aurbach Y, Wasserman M et al (1995) Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45(5):486–490PubMedCrossRef Klipper-Aurbach Y, Wasserman M et al (1995) Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45(5):486–490PubMedCrossRef
Zurück zum Zitat Lahoud MH, Ristevski S et al (2001) Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11(8):1327–1334PubMedCrossRef Lahoud MH, Ristevski S et al (2001) Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11(8):1327–1334PubMedCrossRef
Zurück zum Zitat Lautner-Csorba O, Gézsi A et al (2012) Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 5:42PubMedCrossRef Lautner-Csorba O, Gézsi A et al (2012) Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 5:42PubMedCrossRef
Zurück zum Zitat Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36(Database issue): D820–D824 Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36(Database issue): D820–D824
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408 Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Zurück zum Zitat Lopez-Lopez E, Martin-Guerrero I et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57(4):612–619PubMedCrossRef Lopez-Lopez E, Martin-Guerrero I et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57(4):612–619PubMedCrossRef
Zurück zum Zitat Orsi L, Rudant J et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26(12):2561–2564PubMedCrossRef Orsi L, Rudant J et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26(12):2561–2564PubMedCrossRef
Zurück zum Zitat Pal S, Gupta R et al (2012) Alternative transcription and alternative splicing in cancer. Pharmacol Ther 136(3):283–294PubMedCrossRef Pal S, Gupta R et al (2012) Alternative transcription and alternative splicing in cancer. Pharmacol Ther 136(3):283–294PubMedCrossRef
Zurück zum Zitat Papaemmanuil E, Hosking FJ et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010PubMedCrossRef Papaemmanuil E, Hosking FJ et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010PubMedCrossRef
Zurück zum Zitat Pastorczak A, Górniak P et al (2011) Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 35(11):1534–1536PubMedCrossRef Pastorczak A, Górniak P et al (2011) Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 35(11):1534–1536PubMedCrossRef
Zurück zum Zitat Paulsson K, Forestier E et al (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107(50):21719–21724PubMedCrossRef Paulsson K, Forestier E et al (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107(50):21719–21724PubMedCrossRef
Zurück zum Zitat Perry GH, Ben-Dor A et al (2008) The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82(3):685–695PubMedCrossRef Perry GH, Ben-Dor A et al (2008) The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82(3):685–695PubMedCrossRef
Zurück zum Zitat Prasad RB, Hosking FJ et al (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767PubMedCrossRef Prasad RB, Hosking FJ et al (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767PubMedCrossRef
Zurück zum Zitat Samuelsson J, Alonso S et al (2011) Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer. Int J Oncol 38(6):1575–1577PubMed Samuelsson J, Alonso S et al (2011) Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer. Int J Oncol 38(6):1575–1577PubMed
Zurück zum Zitat Treviño LR, Yang W et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005PubMedCrossRef Treviño LR, Yang W et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005PubMedCrossRef
Zurück zum Zitat Vijayakrishnan J, Sherborne AL et al (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51(10):1870–1874PubMedCrossRef Vijayakrishnan J, Sherborne AL et al (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51(10):1870–1874PubMedCrossRef
Zurück zum Zitat Xu H, Cheng C et al (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30(7):751–757PubMedCrossRef Xu H, Cheng C et al (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30(7):751–757PubMedCrossRef
Zurück zum Zitat Yang W, Treviño LR et al (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 24(4):894–896PubMedCrossRef Yang W, Treviño LR et al (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 24(4):894–896PubMedCrossRef
Metadaten
Titel
Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility
verfasst von
Ángela Gutiérrez-Camino
Elixabet López-López
Idoia Martín-Guerrero
José Sánchez-Toledo
Nagore García de Andoin
Ana Carboné Bañeres
Purificación García-Miguel
Aurora Navajas
África García-Orad
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2013
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-013-1512-3

Weitere Artikel der Ausgabe 11/2013

Journal of Cancer Research and Clinical Oncology 11/2013 Zur Ausgabe

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

ASS schützt nicht vor Brustkrebsrezidiven

02.05.2024 Mammakarzinom Nachrichten

Nützt nichts und ist vielleicht sogar schädlich: In einer Phase-3-Studie konnten täglich 300 mg ASS keine Brustkrebsrezidive bei Frauen vermeiden, die ein hohes Risiko für eine Tumorrückkehr aufwiesen. Tendenziell traten unter ASS sogar häufiger Rezidive auf als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.